ClinicalTrials.gg
Not yet recruitingNCT06979063Updated May 18, 2025

Health Education for Women With Suspeced Infertility Waiting for Specialized Care

An interventional study of Remote Infertility Education and Counseling and Standard Care Arm in Infertility, Health Education and Telemedicine, sponsored by Hospital de Clinicas de Porto Alegre. Not yet recruiting at 1 site in Brazil. Open to female participants aged 18 Years to 34 Years. Per ClinicalTrials.gov, last updated 2025-05-18.

Sponsored by Hospital de Clinicas de Porto Alegre · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
206
Allocation
Randomized
Ages
18 Years to 34 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Infertility with a site in Brazil — 3 open to participants now, 3 under way, none of them phase 3. Infertility · Brazil.

Planned enrollment
10th of 31
206 · median 100
Started
2025
with 1 other
No phase
22 of 34
3 open now
Registered
31st of 34
by date
Lead sponsor
3 of 34
Hospital de Clinicas de Porto Alegre

Among the 34 studies in Infertility with a site in Brazil, this one is the 10th largest by planned enrollment of the 31 interventional ones that give a count, is one of 2 that started in 2025, is one of 22 with no phase, and was the 31st registered.

Infertility

2,090 studies on the registry are indexed under Infertility; 355 are open to participants now.

Browse Infertility studies →

Open to participants now

3 of the 34 studies in Infertility with a site in Brazil are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 232 Infertility studies recruiting now, 43 (19%) set no upper age limit and 183 (79%) stop at 75 or younger; 27 take children under 18; 74 take healthy volunteers.

This study: 18 Years to 34 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Infertility with a site in Brazil, or all of them as a file.
02

Study summary

Introduction: Infertility is defined as a couple's inability to achieve pregnancy after 12 months or more of regular unprotected intercourse. In Brazil, it affects around eight million people. While health services provide resources for contraception, little attention is given to supporting conception and preserving fertility.

Objective: To evaluate the effectiveness of a remote educational and counseling intervention on infertility.

Method: Open-label randomized clinical trial. Couples referred for infertility will be identified in the electronic referral system. For inclusion, the woman of the couple must be 34 years old or less, no previous in-vitro fertilization attempts, and have access to telephone or internet. The control group will follow standard care, awaiting in-person consultation. The intervention group will also wait for in-person evaluation but receive additional education and counseling via video call.

The primary outcome is the proportion of correct referrals according to local protocols. A total of 206 participants will be included to detect a difference between success rates of 50% and 30%, with 80% power and a 5% significance level.

03

Conditions studied

  • Infertility
  • Health Education
  • Telemedicine
  • Telehealth
04

Who can participate

Ages eligible
18 Years to 34 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals referred to specialized infertility care in Porto Alegre.
  • Age up to 33 years and 11 months.

Exclusion criteria

Exclusion Criteria:

  • Lack of access to the internet or telephone.
  • Prior specialized infertility treatment in the private healthcare system.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
206 participants (estimated)

Study arms

  • Active comparator
    Standard care

    Wait for specialized infertility consultation, following the usual health system process.

    Other: Standard Care Arm

  • Experimental
    intervention group

    Remote counseling and education about infertility and healthcare system navigation.

    Other: Remote Infertility Education and Counseling · Other: Standard Care Arm

Interventions

  • OtherRemote Infertility Education and Counseling

    Patients receive video call counseling covering infertility investigation, non-pharmacological fertility enhancement strategies, and healthcare navigation guidance. Health professionals review patient records and request missing infertility-related exams according to local protocol. Additional follow-ups occur approximately every 30 days to assist with pending investigations. If significant findings arise, patients will receive an explanation and assistance in scheduling primary care consultations.

  • OtherStandard Care Arm

    Referrals from patients will be avaluated following local protocols in the electronic referral system. Incomplete data will be requested through this system. There will be no direct contact with patients.

06

What researchers measure

Primary outcomes

  1. Correct referral

    Proportion of participants correctly referred to specialized care according to local protocols.

    Time frame: Six months after randomization

Secondary outcomes

  1. Proportion of patients with conception plan achieved.

    Patient-reported conception plan will be evaluated by interview to assess whether pregnancy was achieved or it was opted to forgo the plan.

    Time frame: Six months after randomization

  2. FertiQoL

    Change in Quality of Life as Measured by the Fertility Quality of Life (FertiQoL) Questionnaire. The FertiQoL is a validated instrument that measures quality of life in individuals experiencing fertility problems. Scores range from 0 to 100, where higher scores indicate better quality of life.

    Time frame: Six months after randomization

  3. Time to regulation decision

    Time in days between the referral and final decision for the referral

    Time frame: Six months after randomization

  4. Time for in-person consulting

    Time in days between the referral and in-person consult.

    Time frame: Six months after randomization

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2025; primary completion for Dec 2026, 18 months later.

Of 385 non-industry interventional studies with no phase under Infertility, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 18 months is below that.

Counting every sponsor, half of 415 studies reached it within 24 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 24, 2025
First posted
May 18, 2025
StartEst.
Jun 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
May 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06979063
Collaborators
Telessaúde RS
Responsible party
Michele Zschornack Strelow (Principal Investigator, Hospital de Clinicas de Porto Alegre) — Principal investigator
First posted
May 18, 2025
Start date
Jun 2025 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 18, 2025

Study contacts

Michele Strelow Moreira
Contact
mstrelowmoreira@gmail.com
+5551992607430
Helena von Eye Corleta
Contact
hcorleta@hcpa.edu.br
51999862749

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion